Evidence map›Paper›PMID 25320232›Full record

ArticleScience translational medicine2014

Blocking PirB up-regulates spines and functional synapses to unlock visual cortical plasticity and facilitate recovery from amblyopia.

David N Bochner, Richard W Sapp, Jaimie D Adelson, Siyu Zhang, Hanmi Lee, Maja Djurisic, Josh Syken, Yang Dan, Carla J Shatz

Abstract read
In one paragraph

Article in Science translational medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. C4d, a high-affinity LilrB2 ligand, is elevated in Alzheimer's disease and mediates synapse pruning.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Genome-Wide Association Analysis Identifies LILRB2 Gene for Pathological Myopia.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  8. Immune receptors and aging brain.Bioscience reports · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

David N BochnerDepartment of Biology and Bio-X, James H. Clark Center, Stanford University, Stanford, CA 94305, USA.
Richard W SappDepartment of Biology and Bio-X, James H. Clark Center, Stanford University, Stanford, CA 94305, USA.
Jaimie D AdelsonDepartment of Biology and Bio-X, James H. Clark Center, Stanford University, Stanford, CA 94305, USA.
Siyu ZhangDivision of Neurobiology, Department of Molecular and Cell Biology and Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
Hanmi LeeDepartment of Biology and Bio-X, James H. Clark Center, Stanford University, Stanford, CA 94305, USA.
Maja DjurisicDepartment of Biology and Bio-X, James H. Clark Center, Stanford University, Stanford, CA 94305, USA.
Josh SykenVertex Pharmaceuticals Inc., Cambridge, MA 02139, USA.
Yang DanDivision of Neurobiology, Department of Molecular and Cell Biology and Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
Carla J ShatzDepartment of Biology and Bio-X, James H. Clark Center, Stanford University, Stanford, CA 94305, USA. cshatz@stanford.edu.
Vertex Pharmaceuticals (United States) · US

Funding

FETAL AND POSTNATAL DEVELOPMENT OF VISUAL CONNECTIONSR01EY002858 · NEI · STANFORD UNIVERSITY · PI SHATZ, CARLA J · 1985 to 2020
$9.9M
Synapse Remodeling and Neuronal MHC Class IR01MH071666 · NIMH · STANFORD UNIVERSITY · PI SHATZ, CARLA J · 2004 to 2019
$7.6M
Synaptic basis for visual cortical receptive field propertiesR01EY018861 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI DAN, YANG · 2008 to 2016
$3.0M
FETAL AND POSTNATAL DEVELOPMENT OF VISUAL CONNECTIONSR37EY002858 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI SHATZ, CARLA J · 1992 to 2001
$689k
Howard Hughes Medical InstituteNEI NIH HHS EY018861NEI NIH HHS EY02858NEI NIH HHS R01 EY002858NEI NIH HHS R01 EY018861NEI NIH HHS R37 EY002858NIMH NIH HHS MH07166NIMH NIH HHS R01 MH071666
6 · The paper itself

Abstract

During critical periods of development, the brain easily changes in response to environmental stimuli, but this neural plasticity declines by adulthood. By acutely disrupting paired immunoglobulin-like receptor B (PirB) function at specific ages, we show that PirB actively represses neural plasticity throughout life. We disrupted PirB function either by genetically introducing a conditional PirB allele into mice or by minipump infusion of a soluble PirB ectodomain (sPirB) into mouse visual cortex. We found that neural plasticity, as measured by depriving mice of vision in one eye and testing ocular dominance, was enhanced by this treatment both during the critical period and when PirB function was disrupted in adulthood. Acute blockade of PirB triggered the formation of new functional synapses, as indicated by increases in miniature excitatory postsynaptic current (mEPSC) frequency and spine density on dendrites of layer 5 pyramidal neurons. In addition, recovery from amblyopia--the decline in visual acuity and spine density resulting from long-term monocular deprivation--was possible after a 1-week infusion of sPirB after the deprivation period. Thus, neural plasticity in adult visual cortex is actively repressed and can be enhanced by blocking PirB function.

Indexed as

Neuronal PlasticityUp-RegulationAmblyopiaAnimalsAnimals, NewbornDendritic SpinesDominance, OcularGene DeletionGenotypeIntegrasesLigandsMicePyramidal CellsReceptors, ImmunologicRecovery of FunctionSynapsesCre recombinaseIntegrasesLigandsPirb protein, mouseReceptors, ImmunologicTamoxifen

Identifiers

PMID25320232
PMCPMC4476552
OpenAlexW4212897917

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.